English | 简体中文 | 繁體中文 | 한국어 | 日本語
Sunday, 20 September 2020, 13:13 HKT/SGT
Share:
Mitsubishi Chemical: Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua

HONG KONG, Sept 20, 2020 - (ACN Newswire) - A Mitsubishi Chemical (MTLHY) technical expert revealed that the important innovations of Tesla's new battery are the positive and negative electrodes and the new electrolyte. Mitsubishi Chemical has perfectly matched the electrolyte technology for the new battery. This electrolyte mainly uses new solutes and functional additives, which can greatly improve battery performance. The technical expert said that the solvent in the new electrolyte is still supplied by the Chinese company Shida Shenghua, and the amount of DMC in the solvent will be greatly increased. Beginning in 2017, Mitsubishi and Shida Shenghua have jointly developed a new type of solute. This product will soon be mass-produced, which can effectively increase battery cycle times and energy density.


Topic: Press release summary Sectors: Daily Finance, Chemicals, Spec.Chem, Energy, Alternatives, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Hong Kong Tech Innovators Drive Success at Mobile World Congress and 4YFN Barcelona 2026  
Mar 6, 2026 13:08 HKT/SGT
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season  
Mar 6, 2026 12:12 HKT/SGT
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026  
Mar 6, 2026 10:00 HKT/SGT
TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C  
Thursday, March 5, 2026 9:00:00 PM
Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors  
Mar 5, 2026 17:29 HKT/SGT
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity  
Mar 5, 2026 16:00 HKT/SGT
Honda to Begin Sales of Two U.S.-built Vehicles in Japan  
Thursday, March 5, 2026 3:47:00 PM
DOCOMO's New Haptic-sharing System Enables Fans to Feel Closer to Idols  
Thursday, March 5, 2026 3:38:00 PM
Galaxy Corporation Leads "K-Entertech" IPO Rush as Nasdaq Vice Chairman's Surprise Visit Boosts Listing Prospects  
Mar 5, 2026 15:30 HKT/SGT
Core Concepts Physiotherapy Partners with Podiatry Quest to Deliver Enhanced Assessments for Patients with Plantar Fasciitis  
Mar 5, 2026 12:30 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575